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Summary 
Peripheral neuropathy remains a major complication of diabetes. Numerous etiological theories of metabolic and/or vascular 
disturbances have been suggested including decreased endoneurial oxygen tension with presumed tissue hypoxia. Increases in the affinity 
of hemoglobin for oxygen (Hb-O2 affmity) may also produce tissue hypoxia and such Hb-O2 affinity changes have been implicated in 
the pathogenesis of diabetic microangiopathy. In order to test whether affinity hypoxia might contribute to the development of diabetic 
peripheral neuropathy, we have utilized a rat model of high and normal Hb-O2 affinity produced by backcrossing animals with increased 
and decreased levels of 2,3-diphosphoglycerate (DPG). Diabetes was induced in ten high and ten low DPG animals with a tail veto 
injection of 55 mg/kg streptozotocin (STZ). Five animals in each group were treated with 2.4 U protamine zinc insulin (PZI)/day while 
the remaining animals were untreated. All rats were killed after 30 days, sections of tibial and surai nerve were rapidly removed and 
processed for teased fiber analysis. A minimum of 125 axons were assessed per nerve for E degeneration (myelin ovoids) using the 
classification developed by Dyck et al. Untreated animals, regardless of DPG levels, demonstrated 0~o neuropathy. In contrast, all 
insulin-treated animals showed degeneration (0.4-17 ~o) that inversely correlated with the DPG level (r = - 0J59, P < 0.04). The results 
of this study suggest that the level of RBC DPG (and presumably the Hb-O2 affinity) with its attendant effect on tissue oxygen release 
may play a role in the development of peripheral neuropathy in STZ-induced diabetic rats treated with insulin. 
Introduction 
Peripheral nerve degeneration is a major source of 
morbidity in diabetes mellitus. At least 2.5 million patients 
in the United States alone have been diagnosed as having 
diabetic neuropathy (Thomas et al. 1984). The etiology 
and/or pathogenesis of this diabetic sequel remains elusive 
although many theories seeking to explicate it are extant. 
These theories generally fall into two categories, vascular 
and metabolic, and have been reviewed extensively (Dyck 
1989; Dyck et al. 1985; Greene et al. 1988; Low 1987; 
Windebank 1983). The majority of these theories have 
focused on the diabetic state per se with little emphasis on 
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the treatment methods and their potential contributory role 
in exacerbating neuropathy symptoms. 
Ditzel (1980) has hypothesized that increases in the 
oxygen affinity of hemoglobin producing tissue hypoxla 
(affinity hypoxia) associated with insulin treatment may be 
responsible for many of the pathologic changes seen in the 
microcirculation of diabetes with microangiopathy. He was 
able to demonstrate that in diabetes, alterations in hemo- 
globin-oxygen (Hb-O2) affinit~ were correlated inversely 
with Levels of red blood cell (RBC) 2,3-diphosphoglycerate 
(DPG" Ditzel 1980; Ditzel et at. 1975. 1977; Standl etal.  
1976). We postulated that neuropathic changes observed in 
the peripheral nerves of insulin-treated experimental 
diabetic rats might also be related to affinity hypoxia and 
D P G  levels via microvascular changes in the vasa 
nervosum. Therefore, we predicted that animals with high 
RBC levels of D P G  would exhibit less peripheral nerve 
degeneration than animals with normal levels of RBC D P G  
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when both were rendered diabetic and treated with insulin. 
The availability of an animal model with high and normal 
DPG strains enabled us to test our hypothesis. The model 
was developed by one of the authors by backcrossing high 
DPG heterozygous Long Evans Hooded rats to homo- 
zygous normal D P G  Lou rats (Brewer et al. 1979), 
Materials and methods 
Fifteenth generation 8-week-old male rats as described 
were utilized. Ten normal D P G  and 10 high DPG rats were 
all rendered diabetic by tail vein injection of streptozotocin 
(55 mg/kg). Five animals in each group were randomly 
selected for daily treatment with protamine zinc insulin 
(PZI: 2.4 units/day) while 5 in each group were untreated. 
Baseline measures included weight, hematocrit, plasma glu- 
cose (Beckman Glucose Analyzer, Beckman Instruments, 
Fullerton, CA), RBC DPG and ATP (Sigma kits, Sigma 
Technical Bulletins 366 and 35-UV). DPG and ATP were 
measured individually by separate methods. The 
DPG values and the ATP values were then added together 
since their effect on O2 affinity is equal. Measures were 
repeated at intervals for the duration of the study. After 
4 weeks of treatment, plasma insulin levels were assayed 
from serum obtained at death by single antibody equi- 
librium method using Wright guinea pig serum antiporcine 
insulin modification of Heding's method (Heding 1972). 
Glucagon values were also obtained at death from serum 
using Eisentraut's modification of Unger's method (Unger 
et al. 1962). At baseline and during the study, blood was 
obtained viatail vein cannulation while blood at death was 
from heart puncture. Prior to sacrifice, animals were anes- 
thetized with Nembutol. The sural and tibial nerves were 
fixed in 1.51!,, glutaraldehyde. 0.05 I',, paraformaldehyde in 
0.08 M Sorensen's phosphate buffer for 3 h at room tem- 
perature and postfixed with osmium tetroxide in Sorensen's 
buffer for an additional 3 h. The specimens were dehydrated 
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in graded alcohol concentrations and immersed in Epon 
with toluene as an intermediary solvent. Teased fiber prepa- 
rations were prepared on sural and tibial nerves according 
to methods described by Dyck et al. (1984) and all quantifi- 
cation of teased fiber preparations was done according to 
the classification system developed by Dyck et al. (1984). A 
minimum of 125 fibers were counted for each nerve under 
blinded conditions. The number of fibers demonstrating 
condition "E" (myelin ovoids - wallerian degeneration) 
were counted per total number of fibers sampled and a 
percent degeneration score was calculated for each nerve. 
Statistical analyses included analysis of variance for 
repeated measures, paired and unpaired t-tests where 
appropriate, and Spearman rank correlation. 
Results 
The animals in this study exhibited typical physiologic 
profiles for insulin and non-insulin treatment (Table 1). 
There were no differences in beginning values for weight 
(171 + 10 vs 166 _+ 12) or Hct (43 _+ 3 vs 42 + 2) between 
the normal and high DPG groups. Two animals in the 
normal D P G  untreated group died prior to sacrifice. The 
DPG + ATP levels in the 2 groups differed at baseline and 
remained so at sacrifice (Fig. 1). However, complete sepa- 
ration of DPG levels did not occur: two insulin-treated 
animals in the "normal" group had levels which overlapped 
with those seen in the "high" group. 
All untreated animals in both the high and normal 
DPG groups demonstrated 0"0 degeneration in teased fiber 
preparations from sural and tibial nerves. All insulin- 
treated animals from both groups displayed degeneration 
ranging from 0.4 to 17'!i,. For the insulin-treated animals, 
there was an inverse correlation between DPG + 
ATPlevels and percent degeneration (r = -0.59,  
P < 0.04; Fig. 2). No significant correlation could be dem- 
onstrated between percent neuropathy and mean (weekly) 
TABI.E 1 
TERMINAL VALUES 
Mean + SD. 
Group (n) Hct Insulin Glucagon Glucose Weight 
( °,, ) (/~ U/ml) (pg/ml) (mg/dl) (g) 
Controls (normal DPG) 
Untreated (3) 32 _+ 5 5.9 _+ 2.3 760 _+ 212 727 _+ 26 173 + 6 
Treated (5) 42 + 2 105.2 + 59.9 225 _+ 52 246 _+ 109 249 _+ 17 
High DPG 
Untreated (5) 32 + 2 4.8 _+ 1.8 645 _+ 120 755 _+ 12 164 + 15 
Treated (5) 39 + 5 153.1 _+ 103.0 212 + 32 280 _+ 170 241 + 6 
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Fig. 1. Baseline and pre-sacrifiee DPG + ATP levels in the normal DPG 
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Fig. 2. DPG + ATP levels in insulin-treated rats vs°,o degeneration in 
the same animals (Spearman rank correlation). 
blood glucose or with terminal or final blood glucose levels. 
Utilizing multiple regression analysis, neither glucagon, 
insulin, weight or glucose levels could be related to percent 
neuropathy after DPG + ATPlevels were taken into 
account. 
Discuss ion  
The major finding in this study, that there is an inverse 
correlation between RBC levels of D P G  and percent degen- 
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Fig. 3. Effect of Hb-O2 shifts on 02 extraction. As the Pso increases (tess 
Hb-O z affinity, dotted line), the arterial saturation changes little. How- 
ever, the venous saturation decreases to a much greater degree with a 
resultant increase in the A-V 02 difference, x > y (see text)i 
eration supports the concept that tissue hypoxia induced by 
changing Hb-O 2 affinity may play a role In exacerbating 
diabetic peripheral neuropathy. Insulin has been shown to 
decrease the Pso, defined as the partial pressure (PO2) of 
oxygen required to half saturate hemoglobin (Shappell et al. 
1975). When the Pso decreases, the oxyhemoglobin disso- 
ciation curve shifts to the left (Fig. 3). Because the curves 
are flat on the top, the difference in saturation for a given 
PO 2 on the arterial side is small: however, the difference in 
saturation for a given PO2 on the venous side is much 
greater, Thus, with a left-shifted curve, the arteriovenous 
oxygen difference is decreased, theoretically resulting in 
diminished tissue oxygen delivery. Each millimeter change 
in the Pso may result in as much as a 7 ~o change in tissue 
oxygen saturation (Shappell et al. 1975J. Ditzel has shown 
that the mean decrease in oxygen release calculated from 
the measured fall in the Pso foIlowing subcutaneous insuhn 
in non-acidotic diabeucs averaged 12'!~,, (Ditzel 1980. 
Standl et al. 1976). 
Prominent among the factors known to affect Pso ~s 
DPG. Increases in DPG produce increases in the Pso or a 
rightward shift in the oxyhemoglobin dissociation curves 
resulting in enhanced tissue oxygenation, while decreases in 
DPG produce the opposite result. Changes in ATP produce 
similar effects to DPG (Ditzet 1980: Shappell et al. 1975). 
Bolus administration of in sulin lowers plasma inorgamc 
phosphate with a resultant decrease in DPG production 
and a decrease in the Ps~ (Ditzel 1980: Ditzel et al. 1976bF 
The relative tissue hypoxla induces compensatory micro- 
vascular vasodilation with both increased blood flow and 
capillary permeability. Over time, such metabolic fluxes 
may lead to significant hyperemia and tissue damage. These 
problems in tissue oxygenation induced by bolus insulin 
therapy are superimposed upon the reduced oxygen ex- 
traction caused by hyperglycemia and elevated levels of 
glycosylated hemoglobin since increased HbA~C produces 
a decrease in the Pso with diminished tissue oxygen ex- 
traction (Ditzel 1976a, 1980; Ditzel et al. 1979). 
Other investigators have reported a decrease in endo- 
neurial POo in diabetic animals prompting them to hypothe- 
size a vascular-hypoxia etiology for the peripheral nerve 
degeneration seen in diabetes (Dyck 1989; Low 1987). 
Such findings could be produced by affinity hypoxia with 
its resultant lack of tissue oxygen release. 
Insulin injected as a bolus often produces hypoglycemia 
which has also been suggested as an etiologic factor in 
causing peripheral nerve degeneration (Jakobsen et al. 
1987; Potter et al. 1988). We found no correlation between 
mean or trough blood glucose levels and percent degen- 
eration in this study. |t is likely that bolus insulin produces 
hypoglycemia and hypophosphatemia with decreased Pso; 
however, in the present study, the differing DPG and 
Pso levels may have obscured this relationship. 
The evidence to date suggests that the etiology of 
diabetic peripheral neuropathy is the result of interaction 
among multiple factors including a direct action of insulin 
on peripheral nerve fibers which could at least partly explain 
the results observed (Dyck 1989; Greene et al. 1988; Low 
1987). Although actual measurements of nerve oxygen 
tension were not made, data from this study lend indirect 
support to the mounting evidence that there is a hypoxic 
component contribution to the diabetic neuropathic con- 
dition ; the exact mechanism whereby affinity hypoxia con- 
tributes to the production of peripheral neuropathy remain s 
to be studied. Naturally, the relevance of results obtained 
in studies on induced diabetes in animals to the human 
diabetic condition considering factors such as varying in- 
duction time and genetic homogeneity remain to be proven. 
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